NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-103-2007-0-US-01 Improved DNA Vaccination Protocols US 60/934,366 Abandoned
CC E-215-2005-0-EP-05 SYSTEM FOR IMAGE-GUIDED ENDOVASCULAR PROSTHESIS AND METHOD FOR USING SAME EP National Stage 07798380.7 Issued
CC E-215-2005-0-CA-04 Electromagnetically Trackable, Non-ferromagnetic Scalpel, Clamp, And Surgical Tools2,659,586 CA National Stage 2659586 Issued
CC E-215-2005-0-US-02 System for Image-Guided Endovascular Prothesis And Method for Using Same US ORD 11/761,134 8041412 Issued PDF
NCI E-207-2007-1-US-01 N4 Modification Of Nucleotides For Increased Stability, Oral Boavailability, Targeted Delivery And Combination Therapy US 60/943,172 Abandoned
CC E-215-2005-0-PCT-03 Electromagnetically Trackable, Non-ferromagnetic Scalpel, Clamp, And Surgical Tools PCT PCT PCT/US07/070884 Expired
NIA E-216-2007-0-AU-03 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE AU National Stage 2007258479 Abandoned
NIA E-216-2007-0-PCT-02 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE PCT PCT PCT/US2007/013607 Expired
NIA E-216-2007-0-US-06 Method of Reducing Amyloid-Beta Peptide Levels Using a Bisdioxopiperazine US National Stage 12/308,027 Abandoned
NIA E-216-2007-0-EP-05 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE EP National Stage 07795945.0 Abandoned
NCI E-059-2001-1-US-02 Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US DIV 11/760,638 Abandoned
NIA E-216-2007-0-CA-04 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE CA National Stage 2654791 Abandoned
NIA E-216-2007-0-IL-07 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE IL National Stage 195765 Abandoned
NIA E-216-2007-0-IN-08 A METHOD OF REDUCING AMYLOID-BETA PEPTIDE LEVELS USING A BISDIOXOPIPERAZINE IN National Stage 147/DELNP/2009 Abandoned
NCI E-215-2007-0-US-01 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE AND DETECTING HEPATIC STEM CELLS US 60/942,833 Abandoned
NIAID E-019-2007-1-US-01 Vaccines Against Potential Pandemic Strains Of Influenza US 60/942,804 Abandoned
NCI E-287-2007-2-US-01 Deacetylase Inhibitor Therapy US ORD 11/759,471 8957027 Issued PDF
NIAID E-239-2007-0-US-01 PMS Gene Peptides As Vaccine Targets Against Methicillin-resistant Staphylococcus Aureus US 60/933,573 Abandoned
NCI E-314-2005-0-PCT-02 Singh Intracavitary Balloon Brachytherapy System (SIBBS) PCT PCT PCT/US07/013268 Abandoned
CC E-298-2006-0-US-01 SEGMENTING COLON WALL VIA LEVEL SET TECHNIQUES US ORD 11/810,704 8175348 Issued PDF
NCI E-090-2009-1-US-01 Systems And Methods For High Throughput, Minimally-Invasive Radiation Biodosimetry US 60/942,090 Abandoned
NCI E-290-2006-1-US-01 MicroRNA Expression Pattern Associated With Colon Adenocarcinoma And Which Predicts Poor Prognosis And Response To Chemotherapy US 60/932,736 Abandoned
NCI E-233-2006-2-PCT-01 RNA NANOPARTICLES AND NANOTUBES PCT PCT COMB PCT/US2007/013027 Expired
NCI E-233-2006-2-EP-04 RNA Hexagonal Ring And RNA Nanotube EP National Stage 07861316.3 Abandoned
NHLBI E-249-2006-1-US-01 A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA) US 60/932,611 Abandoned
NHGRI E-217-2007-0-US-01 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT US 60/932,451 Abandoned
NCI E-213-2007-0-US-01 A Novel Class Of HIV Drugs Built On Dendrimeric And Other Flexible Scaffolds US 60/932,464 Abandoned
NCI E-233-2006-2-CA-03 RNA Hexagonal Ring And RNA Nanotube CA National Stage 2654174 Abandoned
NCI E-233-2006-2-AU-02 RNA Hexagonal Ring And RNA Nanotube AU National Stage 2007300734 Abandoned
NCI E-164-2007-0-US-01 Compounds Binding To The N-terminal Domains Of STAT Proteins As Therapeutic Agents US 60/940,916 Abandoned
NCI E-245-1994-0-US-20 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CON 11/022,091 Expired
NCI E-245-1994-0-US-38 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CON 11/807,004 7462356 Abandoned PDF
NHLBI E-188-2006-0-PCT-02 Transformed Human CD36+ Cells Allow Productive Parvovirus B19 Infection PCT PCT PCT/US2007/012645 Expired
NCI E-224-2007-0-US-01 Gene Modification Of Anti-tumor T Cells Using Micro-RNA (miRNA) US 60/940,172 Abandoned
NCI E-029-2006-1-EP-04 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF EP National Stage 06837414.9 Issued
NIDDK E-149-2006-1-US-01 Three Genes That Either Enhance Growth In HEK-293 Cells Or Modify Adhesion In HeLa Cells US 60/931,439 Abandoned
NCI E-264-2004-0-US-03 Combining Phage Lambda Genetics And Protein Display For The Identification Of Multi Complex Protein Structures. US National Stage 11/719,925 Abandoned
NHLBI E-237-2003-0-US-03 Fisptrain: A High Signal Magnetic Resonance Imaging (MRI) Sequence With Steady-state Free Precession And Intrinsic Fat Suppression US CON 11/751,479 7880466 Issued PDF
NCI E-057-1994-2-US-11 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/751,233 7612044 Expired PDF
NIAID E-171-2007-0-US-01 Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFJ1 In Cell Culture US 60/931,259 Abandoned
NIAID E-174-2007-0-US-01 Pseudocoelomic Fluid From Ascaris Serum Protects From Allergic Diseases US 60/924,537 Abandoned
NIAID E-220-2007-0-US-01 Gram Positive Three-Component Antimicrobial Peptide-Sensing System US 60/930,709 Abandoned
NEI E-094-2003-0-US-03 Steroid Formulation And Methods of Treatment Using Same US National Stage 11/791,125 Abandoned
NIDDK E-223-2006-0-EP-05 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS EP National Stage 07777162.4 Abandoned
NIDDK E-223-2006-0-JP-06 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS JP National Stage 2009-511097 Abandoned
NIDDK E-223-2006-0-PCT-02 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS PCT PCT PCT/US07/011951 Expired
NIDDK E-223-2006-0-AU-03 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS AU National Stage 2007254165 Abandoned
NIDDK E-223-2006-0-CA-04 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS CA National Stage 2652061 Abandoned
NINDS E-014-2006-2-HK-09 Assays For Diagnosing and Evaluating Treatment Options for Fabry Disease HK EP 09107461.6 Issued
NINDS E-014-2006-2-IT-32 Treatment Options For Fabry Disease IT EP 12168451.8 Issued